Joachim H. Ficker
机构: Paracelsus Medizinische Privatuniversität Nürnberg
主页: lungenzentrum.de
每年引用次数
引用次数
引用: 8,739
H-指数: 43
I10-指数 : 88
出版物: 457
Detection of obstructive sleep apnea by analysis of phase angle using the forced oscillation signal.
S Reisch , J Timmer , H Steltner , K.H Rühle
Respiration Physiology 123 ( 1) 87 -99
9
2000
Arousals: Aktueller Stand, Klinische Bedeutung und offene Fragen
Karl-Heinz Ruhle12 , Friedhart Raschke9 , Holger Hein3 , Joachim H. Ficker1
Somnologie - Schlafforschung Und Schlafmedizin 5 ( 1) 24 -45
11
2001
Launois-Bensaude syndrome in a female with type 2 diabetes.
Igor Alexander Harsch , Joachim Hans Ficker , Eckhart Georg Hahn , Patrick Michaeli
Medical Science Monitor 9 ( 2)
6
2003
Prognostic and predictive value of estrogen receptor 1 expression in completely resected non-small cell lung cancer.
Wolfgang Michael Brueckl , Salah-Eddin Al-Batran , Joachim Hans Ficker , Silke Claas
International Journal of Cancer 133 ( 8) 1825 -1831
16
2013
The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.
Akin Atmaca , Salah-Eddin Al-Batran , Ralph Markus Wirtz , Dominique Werner
International Journal of Cancer 134 ( 10) 2314 -2321
18
2014
The Effect of Continuous Positive Airway Pressure Treatment on Insulin Sensitivity in Patients with Obstructive Sleep Apnoea Syndrome and Type 2 Diabetes
Igor Alexander Harsch , Simin Pour Schahin , Kerstin Brückner , Martin Radespiel-Tröger
Respiration 71 ( 3) 252 -259
196
2004
The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression.
SUSANNE GAHR , CHRISTIAN MAYR , TOBIAS KIESSLICH , ROMANA ILLIG
International Journal of Oncology 47 ( 3) 963 -970
16
2015
In vivo efficacy of heated and non-heated humidifiers during nasal continuous positive airway pressure (nCPAP)-therapy for obstructive sleep apnoea
G.H WIEST , F.S FUCHS , W.M BRUECKL , G NUSKO
Respiratory Medicine 94 ( 4) 364 -368
21
2000
Resistin levels in patients with obstructive sleep apnoea syndrome–the link to subclinical inflammation?
Igor Alexander Harsch1ABE , Corinna Koebnick2CE , Henri Wallaschofski1BG , Simin Pour Schahin1BDF
Med Sci Monit 10 ( 9) 515 -515
132
2004
BIOMARKERS AND TARGETED THERAPIES IN LUNG CANCER... WHERE DO WE STAND AND WHERE WILL WE GO?
WM BRUECKL , J FICKER , TM MUNDEL
EUROPEAN PHARMACEUTICAL REVIEW ( 6)
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Nicolas Schönfeld , Nikolaus Kneidinger , Francesco Bonella , Marion Frankenberger
The Lancet Respiratory Medicine 9 ( 5) 476 -486
1
2021
Afatinib as first-line treatment in patients with EGFR-mutated non-small cell lung cancer in routine clinical practice:
Justyna Rawluk , Cornelius Kortsik , Tobias Gaska , Joachim H Ficker
Therapeutic Advances in Medical Oncology 13 17588359211012361
9
2021
Prognostic value of immune response gene expression in early stage curatively resected NSCLC: Data from the JBR.10 trial.
Wolfgang M. Brueckl , Akin Atmaca , Salah-Eddin Al-Batran , Joachim H Ficker
Journal of Clinical Oncology 34 8528 -8528
2016
Unilateral anhidrosis of the leg.
Joachim H Ficker
The Lancet 360 ( 9327) 129 -129
4
2002
Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort.
Norbert Königsdorfer , Rudolf A Jörres , Sandra Söhler , Tobias Welte
Patient Preference and Adherence 13 1711 -1721
4
2019
Delays in the diagnosis and treatment of women with lung cancer: A systematic analysis.
Wolfgang M. Brueckl , Heide Wagner , Manfred Wagner , Gunther H Wiest
Journal of Clinical Oncology 33 ( 15_suppl) e17740 -e17740
2015
Efficacy of Docetaxel Plus Ramucirumab as Palliative Third-Line Therapy Following Second-Line Immune-Checkpoint-Inhibitor Treatment in Patients With Non-Small-Cell Lung Cancer Stage IV:
Wolfgang M Brueckl , Martin Reck , Achim Rittmeyer , Jens Kollmeier
Clinical Medicine Insights: Oncology 14 1179554920951358
1
2020
Blood vessel invasion (BVI) in curatively (R0) resected stage II and IIIA non-small cell lung (NSCLC) cancer patients.
Wolfgang M. Brueckl , Dieter Wuerflein , Dietmar Kraus , Christian Meyer
Journal of Clinical Oncology 30 ( 15_suppl) e17536 -e17536
2012
Disease-specific medication, patient-reported diagnoses and their relation to COPD severity for common comorbidities in COPD
Tanja Lucke , Ronald Herrera , Margarethe Wacker , Rolf Holle
European Respiratory Journal
2017
Prognostic value of CXLC 9 in patients undergoing neoadjuvant radiochemotherapy and surgery in stage IIIA NSCLC.
Wolfgang Parsch , Ralph M Wirtz , Bettina Braunecker , Dieter Würflein
Journal of Clinical Oncology 36
2018